These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe cholestasis and acute renal failure related to rofecoxib. Linares P; Vivas S; Jorquera F; Olcoz JL; de Leon B; Oritz de Urbina J Am J Gastroenterol; 2004 Aug; 99(8):1622-3. PubMed ID: 15307886 [No Abstract] [Full Text] [Related]
3. A rare case of rofecoxib-induced cholestatic hepatitis. Harsch IA; Michaeli P; Hahn EG; Konturek PC; Klein R Dig Liver Dis; 2003 Dec; 35(12):911-2. PubMed ID: 14703890 [No Abstract] [Full Text] [Related]
4. Acute cholestatic hepatitis associated with long-term use of rofecoxib. Papachristou GI; Demetris AJ; Rabinovitz M Dig Dis Sci; 2004 Mar; 49(3):459-61. PubMed ID: 15139498 [No Abstract] [Full Text] [Related]
17. Upper gastrointestinal toxicity of rofecoxib and naproxen. Gupta S N Engl J Med; 2001 May; 344(18):1398; author reply 1398-9. PubMed ID: 11336057 [No Abstract] [Full Text] [Related]
18. Rofecoxib-associated upper gastrointestinal bleed: a case report. Freedman GM; Kreitzer JM; Badola R Mt Sinai J Med; 2002; 69(1-2):105-6. PubMed ID: 11832981 [TBL] [Abstract][Full Text] [Related]
19. Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib. Ashwath ML; Katner HP Postgrad Med J; 2003 May; 79(931):295-6. PubMed ID: 12782779 [TBL] [Abstract][Full Text] [Related]
20. Rofecoxib-induced pseudoporphyria. Markus R; Reddick ME; Rubenstein MC J Am Acad Dermatol; 2004 Apr; 50(4):647-8. PubMed ID: 15034522 [No Abstract] [Full Text] [Related] [Next] [New Search]